Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†

PURPOSE: To obtain safety and effectiveness data on a combined anti-HIV drug, Epzicom (abacavir 600 mg/lamivudine 300 mg), a post-marketing surveillance on Epzicom that was required by the Japanese regulatory authority was conducted between January 2005 and December 2010. METHODS: A joint survey (HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Tomoko, Kitaichi, Tomomi, Nagao, Takako, Miura, Toshiyuki, Kitazono, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230469/
https://www.ncbi.nlm.nih.gov/pubmed/24590575
http://dx.doi.org/10.1002/pds.3588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230469/
https://www.ncbi.nlm.nih.gov/pubmed/24590575
http://dx.doi.org/10.1002/pds.3588

Ejemplares similares